Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Holding XLV?
Track your performance easily

XLV Price & Analysis

XLV ETF Chart & Stats

Health Care Select Sector SPDR Fund (XLV) Fund Flow Chart

Health Care Select Sector SPDR Fund (XLV) 1 year Net Flows: -$3B

XLV ETF FAQ

What was XLV’s price range in the past 12 months?
XLV lowest ETF price was $122.59 and its highest was $159.64 in the past 12 months.
    What is the AUM of XLV?
    As of Oct 17, 2024 The AUM of XLV is 41.36B.
      Is XLV overvalued?
      According to Wall Street analysts XLV’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does XLV pay dividends?
        XLV pays a Quarterly dividend of $0.58 which represents an annual dividend yield of N/A. See more information on XLV dividends here
          How many shares outstanding does XLV have?
          XLV has 271,965,324 shares outstanding.
            Which hedge fund is a major shareholder of XLV?
            Among the largest hedge funds holding XLV’s share is Swan Global Investments, Llc. It holds XLV’s shares valued at 63M.

              XLV ETF Smart Score

              For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

              Top 10 Holdings

              Name
              Weight %
              Eli Lilly And Company
              12.93%
              Unitedhealth Group Inc.
              9.34%
              Johnson & Johnson
              7.08%
              Abbvie
              5.96%
              Merck & Company
              4.97%
              Thermo Fisher Scientific
              4.09%
              Abbott Laboratories
              3.67%
              Danaher Corporation
              3.13%
              Amgen Inc
              3.09%
              Intuitive Surgical
              3.00%
              Total57.26%

              ETF Description

              Health Care Select Sector SPDR Fund

              XLV tracks health care stocks from within the S&P 500 Index, weighted by market cap.
              Sector
              Sector
              Asset Class
              Equity
              Region
              North America
              Issuer
              SPDR
              Index Tracked
              Health Care Select Sector
              Ticker Symbol
              XLV
              Popular ETFs
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis
              iosandroid
              tipranks
              TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.
              Find Us on
              twitterstocktwitsfacebooklinkedininstagramyoutube
              Newsletter SubscriptionEnter your email to receive our newsletter
              iosandroid
              Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.